BioHack Track models Cerebrolysin at a half-life of 2 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.
No approved product cited
No FDA-approved product for this compound is cited on this page, and no approved human dose is quoted. Treat the range below as research and community practice rather than a prescribed dose.
Reconstitution
Supplied pre-mixed in ampoules.
Storage
Store per manufacturer instructions, typically refrigerated.
Cautions
Not FDA-approved in the US; sourced from animal brain tissue, so origin/purity verification matters.
Track Cerebrolysin in BioHack Track. Half-life, dose range and route come
pre-filled from this library — log a dose and the app counts your vial down, models what is
in your system, and puts it on the same chart as your labs and body composition.
Evidence Check asks 10 questions about every compound. For Cerebrolysin it can answer 2 of them, from the papers we hold — graded by how strong the study design is, not by whether the findings are flattering. These are the same verdicts the app gives.
Some Clinical EvidenceCognition
Clinical trials in humans have looked at this.
Effect of cerebrolysin on neurodevelopmental outcome of high risk preterm infants: A randomized controlled trialRandomized Controlled Trial · J Neonatal Perinatal Med · 2022 · PMID 33935111
[Neuropsychological evaluation of long-term therapy of Alzheimer's disease using different cerebrolysin dosages]Randomized Controlled Trial · Zh Nevrol Psikhiatr Im S S Korsakova · 2005 · PMID 15704485
Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in Alzheimer's Disease Brain Pathology Exacerbated by Sleep DeprivationReview · Adv Neurobiol · 2023 · PMID 37480458
Insufficient EvidenceSleep
Only reviews or early work — not enough to say either way.
Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in Alzheimer's Disease Brain Pathology Exacerbated by Sleep DeprivationReview · Adv Neurobiol · 2023 · PMID 37480458
Research references only. Not medical advice, and not a recommendation to take anything.
Look up the research
These open a search of each database for Cerebrolysin — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
12 papers naming Cerebrolysin in the title, drawn from PubMed and limited to reviews, meta-analyses and trials. Each was checked against PubMed’s own record for its title, journal and year. This is a starting point, not an evidence review — nothing here is offered as support for the dose range above, and the list is not exhaustive. See the editorial policy.
The half-life, route and dose range on this page are compiled from published
pharmacokinetic literature, manufacturer and product monographs where one exists, and the
ranges commonly reported in clinical and research use. They are kept as a range
rather than a single figure because that is what the sources actually support — a
half-life varies with route, formulation and the person.
These are not citations, and this page is not a review of the evidence. Where a
number matters to you, follow the database links above and read the source. We say so
plainly rather than dressing a compiled reference up as one.
Nothing on this page has been reviewed by a named clinician. It is a reference for
people already tracking a protocol, not a recommendation to start one.
Published by Creative Images LLC ·
Last updated ·
Corrections: support
General reference compiled for use
inside the app, not medical advice and not a recommendation to take anything. Dose ranges are
what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.